Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
about
Urinary proteomics and metabolomics studies to monitor bladder health and urological diseasesA statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer.Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkersA study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output.The fascinating story of urine examination: From uroscopy to the era of microscopy and beyond.Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?Metabolomics in bladder cancer: a systematic review.Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancerHuman plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancerMetabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy ControlsNMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.Noninvasive metabolic profiling for painless diagnosis of human diseases and disorders.UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2/STAT3 pathwayNon-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis.A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis.Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.Novel methodologies in analysis of small molecule biomarkers and living cells.A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine.Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways.Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.Discovery of urine biomarkers for bladder cancer via global metabolomics.Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics.Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma.Metabolomic Approaches in Cancer Epidemiology.Metabolomics for the masses: The future of metabolomics in a personalized world.The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.Bladder cancer recurrence surveillance by urine metabolomics analysis.Unmasking molecular profiles of bladder cancer.Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibodyLiquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and MonitoringMetabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
P2860
Q26752864-30AA494D-CA1B-4D5A-A2B6-6620B4F37775Q30977795-894606F1-2806-4FB3-A377-5C29B7F36192Q33591318-4D1C0EA4-B9F6-46EC-B585-972253E89397Q33635038-06B63C5F-D707-4CC4-8432-B1DC07957A74Q33762042-874F4FDE-BB9A-4A24-B4F8-EB3DB9CD8926Q33888970-7F25AB0C-2968-4440-93D4-F00D92D61874Q34855915-134F3F81-F888-4AB7-BF5D-455BA3BE70E7Q35237607-5A8D9141-AAB9-41E9-92F5-18E4388E5F60Q35782652-6EC99622-3B04-407A-BBBC-DEE12C41A1C9Q35813290-BC8228E9-5046-4896-AB2E-DF51EF3339B1Q36046441-65084984-9291-4110-A599-322BC7561642Q36772110-E1599C0D-DB65-4AC7-9C47-9D3B523172BEQ36962829-6105A205-00C0-4FDA-B86C-03EB73E9A99CQ37085946-EE5C1871-783A-4826-B992-50EB1EE00A1CQ37110158-CBE4A8EA-52D6-43D1-8C70-87A30F1F338BQ37301856-9B1FC5F7-9FBB-4328-953F-BA126812F4DDQ37474509-CCFE99CB-0EDA-4A88-883D-A6E744005FA4Q37629009-480B3623-24E5-4BB0-9732-1ABFF4843684Q37665296-6E1F70AF-9636-45DE-A4AB-A43700334172Q37665348-A56A8DA7-F871-4589-A36A-E6DA1BA7D2C9Q37699460-F46641C1-9E9D-4716-A867-8BC0318B33C1Q37739690-64F3B752-6A0B-4575-B970-8EA2A0CB5779Q38239586-BA9D0B47-D17D-469C-ABB5-B14BBD3DB09AQ38371837-19AE9CD3-A9A1-4001-AD4F-F1ACE3E164B6Q38703815-7C7F5C8D-8469-4D3C-B6D9-E2D961A2B1E1Q38709622-FF035E03-538C-43A6-959D-6568D2A6DDEDQ38822316-52F1113C-128C-4220-95CC-D333AF9FA730Q38822368-1AB02FEC-D5E7-4363-8411-EEC2B84B83FAQ40283125-8D058D58-D894-4158-808A-9EB10D8C67C0Q42343447-F6622EE4-966B-46A6-BA04-08C96F9E9D34Q44951888-AA998814-7C27-46B7-BAAA-62747592068CQ46508684-75AD2139-663D-4FA4-B4EF-B7515E67B161Q52363678-F9EF8ABC-6BA6-4BB8-8D0D-D32194DEB838Q55398059-E98EDA8F-A5DA-4A46-B46F-A680188D961CQ55427566-84D8D60D-E488-4863-922A-371BAEF1AA57Q58697139-8CFFD41C-8AF7-48C4-9D1B-FD23E743213EQ58704141-A997FAD3-B585-4407-ABB0-759EEA039F12Q59137458-F4A6912C-2358-40D1-9CB9-43882D345E7F
P2860
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@ast
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@en
type
label
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@ast
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@en
prefLabel
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@ast
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@en
P2093
P2860
P356
P1433
P1476
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
@en
P2093
Isaac Yi Kim
Pildu Jeong
Sunghyouk Park
Wun-Jae Kim
P2860
P304
P356
10.18632/ONCOTARGET.1744
P407
P577
2014-03-01T00:00:00Z